News | ASE | April 21, 2022

American Society of Echocardiography Welcomes Nine New Board Members

New board members to begin serving July 1, 2022.

ASE logo

April 21, 2022 – The American Society of Echocardiography (ASE) is pleased to announce that its membership has elected nine new board members to serve the Society starting July 1, 2022.

The 2022 ASE Executive Committee welcomes newly elected Vice President (one-year term) Theodore Abraham, MD, FASE, University of California at San Francisco, San Francisco, CA, and Secretary (two-year term) Kelly Thorson, DHSc, MSRS, ACS, RDCS, FASE, Lucile Packard Children’s Hospital Stanford, Palo Alto, CA.

In addition to the new officers, the following new Board of Directors members were elected to serve two-year terms: Jose Banchs, MD, FASE, FACC, University of Colorado Anschutz Medical Campus, Aurora, CO (Member at Large); Akhil Narang, MD, FASE, Northwestern Medicine, Chicago, IL (Member at Large); Fadi Shamoun, MD, FASE, Mayo Clinic Arizona, Scottsdale, AZ (Council on Circulation & Vascular Ultrasound Steering Committee Chair); Neha Ringwala Soni-Patel, MEd, RCCS, RDCS (AE/PE), FASE, Cleveland Clinic Children’s, Cleveland, OH (Member at Large); and G. Monet Strachan, ACS, RDCS, FASE, UCSD Medical Center, San Diego, CA (Council on Cardiovascular Sonography Steering Committee Chair). Sujatha Buddhe, MD, MS, FASE, Seattle Children’s Hospital, University of Washington, Seattle, WA (Leadership Academy Representative) and Arthur Labovitz, MD, FASE, Naples Cardiac & Endovascular Center (Retired), Naples, FL (Council on Critical Care Echocardiography Steering Committee Chair) will each serve a one-year term.

Previously elected members of the 2021-2022 ASE Executive Committee transitioning to a new position on the 2022-2023 Board are Stephen Little, MD, FASE, Houston Methodist Hospital, Houston, TX (President); Benjamin Eidem, MD, FASE, Mayo Clinic, Rochester, MN (President-Elect); and Raymond Stainback, MD, FASE, Texas Heart Institute, Houston, TX (Immediate Past President). Cynthia Taub, MD, FASE, Dartmouth Hitchcook Medical Center, Lebanon, NH, will continue serving as Treasurer through June 2024, and Keith Collins, MS, RDCS, FASE, Northwestern Medicine, Chicago, IL, will join the 2022-2023 ASE Executive Committee for a two-year term as the Council Representative.

Directors continuing with their final year of service include Carolyn Altman, MD, FACC, FAHA, FASE, Baylor College of Medicine, Houston, TX (Council on Pediatric & Congenital Heart Disease Steering Committee Chair); Anthony Gallagher MHA, FASE, Baptist Health Lexington, Lexington, KY (Member at Large); Leo Lopez, MD, FASE, Stanford Children’s Hospital, Palo Alto, CA (Member at Large); G. Burkhard Mackensen, MD, PhD, FASE, University of Washington, Seattle, WA (Council on Perioperative Echocardiography Steering Committee Chair); Susan Mayer, MD, FASE, Saint Luke’s Mid America Heart Institute, Kansas City, MO (Member at Large); Kian-Keong Poh, MA, MMed, FRCP, FAMS, FAsCC, FACC, FASE, National University Heart Centre, Singapore (International Representative); Thomas Ryan, MD, FASE, The Ohio State University, Columbus, OH (Past President Member); and Vandana Sachdev, MD, FASE, National Institute of Health, Bethesda, MD (Member at Large).

ASE thanks the following eight Board members who will complete their service on June 30, 2022: Meryl Cohen, MD, MSEd, FASE, FACC, FAHA, Children’s Hospital of Philadelphia, Philadelphia, PA (Council Representative); Judy Hung, MD, FASE, Massachusetts General Hospital, Boston, MA (Immediate Past President); Danita Sanborn, MD, MMSc, FASE, Massachusetts General Hospital, Boston, MA (Member at Large); Vincent Sorrell, MD, FASE, FACP ASIM, FACC, FCMR, University of Kentucky Gill Heart & Vascular Institute, Lexington, KY (Member at Large); Jordan Strom, MD, MSc, FASE, Beth Israel Deaconess, Milton, MA (Leadership Academy Representative); Ritu Thamman, MD, FASE, University of Pittsburgh Medical Center, Pittsburgh, PA (Member at Large); Matt Umland, ACS, RDCS, FASE, Aurora Health Care, Muskego, WI (Secretary); and Bryan Wells, MD, FASE, Emory Healthcare, Atlanta, GA (Council on Circulation & Vascular Ultrasound Steering Committee Chair).

The current 2021-2022 Board of Directors will meet for the final time at ASE’s 33rd Annual Scientific Sessions in Seattle, WA, from June 10-13, 2022.

For more information: ASEcho.org


Related Content

News | Cardiovascular Business

March 29, 2023 — Elucid, Inc., a leading medical technology company providing physicians with AI-powered imaging ...

Home March 29, 2023
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

February was a short but busy month in the diagnostic and interventional cardiology world, with a lot of news being ...

Home March 01, 2023
Home
News | Cardiovascular Business

February 17, 2023 — Internationally recognized cardiologist in heart transplantation Jon Kobashigawa, MD, director of ...

Home February 17, 2023
Home
News | Cardiovascular Business

February 9, 2023 — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has entered into a long ...

Home February 09, 2023
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Here is a recap of what DAIC viewers found most interesting during the month of January: 1. A Dietary Supplement Leads ...

Home February 01, 2023
Home
News | Cardiovascular Business

January 24, 2023 — Cardiothoracic surgeon Thomas E. MacGillivray, MD, from MedStar Health, was elected President of The ...

Home January 24, 2023
Home
News | Cardiovascular Business

January 19, 2023 — The volunteers and staff of the American Heart Association and the American Stroke Association are ...

Home January 19, 2023
Home
News | Cardiovascular Business

January 19, 2023 — Shockwave Medical, Inc., a pioneer in the development of Intravascular Lithotripsy (IVL) to treat ...

Home January 19, 2023
Home
News | Cardiovascular Business

January 11, 2023 — The Alameda, Calif.-based global healthcare company Penumbra has announced U.S. Food & Drug ...

Home January 11, 2023
Home
News | Cardiovascular Business

January 9, 2023 — CinCor Pharma, Inc. announced that it has entered into a definitive agreement with AstraZeneca under ...

Home January 09, 2023
Home
Subscribe Now